Introduction
Recently the benzodiazepines have superseded barbiturates as hypnotics of choice because of their greater efficacy and safety.' 2 Many benzodiazepines are currently available and their relative efficacy usually unknown. We investigated their use in the medical division of Glasgow Royal Infirmary and describe here a trial designed to establish their relative potency in the management of insomnia.
Methods
The use of several hypnotics in Glasgow Royal Infirmary during 1970-4 was determined from data provided by the pharmacy. During 1972-3 a drug surveillance programme was operated within the medical division of this hospital. Records were kept of all drugs administered to patients in the division together with details of the patients' age, sex, and diagnoses. For the present study the frequency of hypnotic drug use was ascertained and details of the prescriptions analysed.
A double-blind randomised trial was then set up to compare the relative efficacy of three benzodiazepine hypnotics: flurazepam (30 mg), nitrazepam (5 mg), and diazepam (5 mg); an antihistamine (promethazine 25 mg); and a placebo, the methods used being similar to those described by Thomson3 and Jick et al. 4 The patients studied were consecutive admissions to medical wards who were conscious, able to communicate a preference to the investigators, and not suffering primarily from hepatic or respiratory insufficiency. None had been previously habituated to hypnotics. All gave their informed consent. The drugs were administered in identical capsules in random order. Five studies were performed comparing each of the drugs with the other. After two nights in hospital patients received one of the drugs on day 3 and the other on day 4. Each drug was given first as often as the other in all comparative groups. On the fifth day their preference was recorded and a record kept of any adverse reactions. In each comparison a limit of 30 preferences was set. Analyses were performed sequentially.4 6 Preference lines were drawn such that line A was crossed when the ratio of preference for drug A over drug B was 2:1 and line B was crossed when the preference ratio was 1:1. Line C was crossed if neither preference line could be crossed within the total number of patients available when the error limits were set at 5% (see fig 2) .
Results

HOSPITAL USE OF SELECTED PSYCHOACTIVE DRUGS
The number of tablets of six index psychoactive drugs purchased annually in Glasgow Royal Infirmary are shown in fig 1. There was a dramatic increase in the use of the two benzodiazepine drugs nitrazepam and diazepam, which was also far greater than the decrease in the use of the other index drugs. A total of 107 patients were admitted to the first part of the patient preference study, 65 (6000') of whom were men. Their mean age was 52 years, mean admission blood urea 5-4 mmol/l (33 mg/100 ml) and their mean packed cell volume 4000.
Flurazepam (30 mg) v placebo-This study showed a statistically significant result at the 500 level in favour of flurazepam in a 2:1 ratio over placebo after 23 patients had been studied (fig 2) . Three patients could not state a preference for either drug, having slept equally well on both occasions.
Flurazepam (30 mg) v nitrazepam (5 mg)-Twenty-two patients participated in this study, and six could not state a preference for either drug. The study was stopped when line C was crossed, indicating a failure to show superiority of one drug over the other within the study limits (fig 2) .
Nitrazepam (5 mg) v diazepam (5 mg)-Twenty-eight patients participated in this study, and 10 failed to state a preference for either drug. The study failed to show significant superiority of nitrazepam over diazepam at the prescribed doses: 10 patients preferred nitrazepam and eight preferred diazepam. In view of the apparent conflict between the above studies the data were scrutinised for possible confounding factors. There was a trend towards a preference for drugs given on the first day of the study over those given on the second day in a ratio of 4:3. Nevertheless, this did not explain the observed differences. In all five studies the distributions of admission blood urea concentrations, packed cell volumes, and discharge diagnosis categories were similar. There were variations in the proportion of men to women between the study groups, but these did not explain the differences. When the age of the patients was analysed it was noted that the youngest patients had, by chance, congregated in the promethazine-flurazepam study. Moreover, when the patient preferences in the nitrazepam-promethazine comparison were analysed by age we found that younger patients preferred promethazine whereas older ones preferred nitrazepam. This hypothesis was therefore tested in a further two studies in which nitrazepam (5 mg) and promethazine (25 mg) were compared separately in two groups of young and old patients who were otherwise similar to each other and to the population originally studied.
Older patients-Twenty-seven patients over 64 years (average age 71) were given nitrazepam (5 mg) and promethazine (25 mg). There was a statistically significant result at the 5% level in favour of nitrazepam in a 2:1 ratio over promethazine. Although six patients showed no preference, 17 
Discussion
Our findings emphasise the extent to which the benzodiazepines are now used in hospital medical practice and also show that different members of this class of drug are often prescribed for different indications in the same patient on the same day. The commonest drugs so prescribed are diazepam, used as an anti-anxiety agent, and nitrazepam, used as a hypnotic. Despite this habit our findings confirm the report of Greenblatt and Shaderl that there is no evidence to sugges. differences in the hypnotic properties of these drugs when given on a short-term basis to medical inpatients. Since there is no pharmacological evidence to support the current practice of using two different benzodiazepines together, and a potential reduction in cost to the Health Service of changing the practice, we undertook a randomised double-blind patient-preference study to test the hypothesis that one of the three commonly used benzodiazepines (flurazepam, nitrazepam, and diazepam) was better than the others as a short-term hypnotic in medical inpatients.
This study design was chosen because of simplicity, economy in staff time, minimum patient interference, use of each patient as his own control, and the benefits of a sequential analysis design. Such trial methods have been shown to be reproducible and reliable in assessing symptomatic drug treatment qualitatively provided only that the basic symptoms under treatment do not vary on a daily basis.' Variability of symptoms in patientpreference studies are of considerable significance and may invalidate the use of this technique. Nevertheless, this did not constitute a significant problem in our study, and Zelvelder, 8 in an extensive review of the techniques of evaluating hypnotics, recommended this approach as the most efficient one available for evaluating short-term hypnotic efficacy. Our studies confirmed that the benzodiazepines are effective hypnotics9 and failed to show a clinically significant difference in efficacy between them when used in this setting. Despite the relatively small numbers of patients, the incidence of undesired effects (usually excessive sedation) seemed to be higher with nitrazepam than with diazepam or flurazepam. Our data also show that older patients admitted to medical wards have a significant preference for a benzodiazepine as a hypnotic rather than an antihistamine.
Spironolactone in essential hypertension: evidence against its effect through mineralocorticoid antagonism 
Summary
The effect of a six-week course of spironolactone 300 mg/ day was examined in 25 unselected patients with essential hypertension. In the blood spironolactone produced a significant rise in urea and potassium concentrations and a fall in sodium and bicarbonate concentrations. In six patients blood pressure was normal at the end of the course, while in five patients there was almost no change. Studies of the effects of spironolactone on various indices usually affected by mineralocorticoids-namely, blood electrolytes, total body potassium, and rectal electrical properties-showed no differences between responding and non-responding patients. Mineralocorticoid excess therefore seems to be rarely responsible for essential hypertension and the influence of spironolactone cannot at present be fully explained. corrects the biochemical abnormalities and usually restores the blood pressure to normal.' In essential hypertension spironolactone in a daily dose of about 100 mg has a hypotensive effect about the same as that of the thiazide diuretics.2 3 Several workers have shown that in essential hypertension spironolactone is especially effective among patients with subnormal blood renin levels (low renin hypertension),4-6 which suggests that low renin hypertension may be due to increased mineralocorticoid activity. Conversely, it has been argued that patients with essential hypertension who respond to spironolactone are likely to have mineralocorticoid excess. Such mineralocorticoid excess has, however, only rarely been shown in hypertensive patients. An alternative suggestion8 is that aldosterone itself is responsible since although the blood levels are within the normal range they may, nevertheless, be inappropriately high for the blood renin concentrations. Our object was to investigate a group of untreated patients with essential hypertension to examine the effect of spironolactone on blood pressure and some biological indices of mineralocorticoid activity to determine whether there was any difference between those patients whose blood pressure responded to spironolactone and those whose blood pressure did not respond. The transepithelial electrical potential difference of rectal mucosa rises considerably when stimulated by aldosterone and other mineralocorticoids,9"13 reflecting the increase of sodium transport, and we used this as one of the indices of mineralocorticoid activity.
Methods
Studies were done on 25 untreated outpatients (14 men, 11 women) whose supine diastolic blood pressures were over 100 mm Hg on at least three occasions. A preliminary observation period of at least four weeks preceded the administration of spironolactone. The mean age
